Company

Pharming Group N.V.

Headquarters: Leiden, Netherlands

Employees: 262

CEO: Dr. Sijmen de Vries M.B.A., M.D., MBA

Euronext: PHARM +2.65%

Market Cap

€516.2 Million

EUR as of July 1, 2024

US$554.4 Million

Market Cap History

Pharming Group N.V. market capitalization over time

Evolution of Pharming Group N.V. market cap in the past 5 years

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Market Cap History of Pharming Group N.V.

Detailed Description

Pharming Group N.V., a specialty pharmaceutical company, develops products for the treatment of rare diseases and unmet medical needs in the United States, Europe, and internationally. The company's lead product is Ruconest, a recombinant human C1 esterase inhibitor that is used for the treatment of acute hereditary angioedema. It also engages in the development of rhC1INH for the treatment of pre- eclampsia, acute kidney injury, and COVID-19; leniolisib, a phosphoinositide 3-kinase delta (PI3K delta) to treat patients with activated activated PI3K delta syndrome; and alpha-glucosidase therapy for the treatment of pompe and fabry diseases. The company has a development collaboration and license agreement with Novartis; and a strategic collaboration agreement with Orchard Therapeutics plc for research, development, manufacturing, and commercialization of OTL-105, an investigational ex vivo autologous hematopoietic stem cell gene therapy for the treatment of hereditary angioedema. Pharming Group N.V. is headquartered in Leiden, the Netherlands.

Top 1-year algo backtest: +265.99%

$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Stocks & Indices

Pharming Group N.V. has the following listings and related stock indices.


Stock: Euronext: PHARM wb_incandescent

Stock: NASDAQ: PHAR wb_incandescent

Stock: FSX: PHGN wb_incandescent

Stock: FSX: PHG wb_incandescent

Stock: OTC: PHGUF wb_incandescent

Details

Headquarters:

Darwinweg 24

Leiden, 2333 CR

Netherlands

Phone: 31 71 524 7400

Fax: 31 71 524 7445